Detection of a circadian enhancer in the mDbp promoter using prokaryotic transposon vector-based strategy by Kiyohara, Yota B. et al.
Published online 5 February 2008 Nucleic Acids Research, 2008, Vol. 36, No. 4 e23
doi:10.1093/nar/gkn018
Detection of a circadian enhancer in
the mDbp promoter using prokaryotic
transposon vector-based strategy
Yota B. Kiyohara
1,2, Keigo Nishii
2, Maki Ukai-Tadenuma
3, Hiroki R. Ueda
3,
Yasuo Uchiyama
1 and Kazuhiro Yagita
1,2,*
1Department of Cell Biology and Neuroscience, Osaka University Graduate School of Medicine, Yamadaoka 2-2,
Suita, Osaka 565-0871,
2COE Unit of Circadian System, Nagoya University Graduate School of Science, Furo-cho,
Chikusa-ku, Nagoya 464-8602 and
3Laboratory for Systems Biology, Center for Developmental Biology, RIKEN,
2-2-3 Minatojima-minaminachi, Chuo-ku, Kobe, Hyogo 650-0047, Japan
Received October 18, 2007; Revised December 27, 2007; Accepted January 12, 2008
ABSTRACT
In mammals, the expression of 5–10% of genes
occurs with circadian fluctuation in various organs
and tissues. This cyclic transcription is thought to
be directly or indirectly regulated through circadian
transcriptional/translational feedback loops con-
sisting of a set of clock genes. Among the clock
genes in mammals, expression of the Dbp mRNA
robustly oscillates both in vivo and in culture cells.
Here, we present circadian enhancer detection
strategy using prokaryotic transposon system. The
mDbp promoter drives reporter gene expression
in robust circadian cycles in rat-1 fibroblasts. To
identify the circadian enhancer generating this
robust rhythm, we developed a prokaryotic trans-
poson-based enhancer detecting vector for in vitro
transposition. Using this system, we identified a
strong circadian enhancer region containing the
CATGTG sequence in the 5’ flanking region of
the mDbp gene; this enhancer region is critical for
the ability of the mDbp promoter to drive robust
oscillation in living cells. This enhancer is classified
as a CANNTG type non-canonical E-box. These
findings strongly suggest that CANNTG-type non-
canonical E-boxes may contribute, at least in part,
to the regulation of robust circadian gene expres-
sion. Furthermore, these data may help explain the
wider effects of the CLOCK/BMAL1 complex in
control of clock output genes.
INTRODUCTION
The mammalian circadian clock is a highly dynamic
system that causes 5–10% of genes to be expressed cycli-
cally; this confers near 24-h rhythmicity on behavior,
physiology and metabolic processes and allows mammals
to adjust to the time of the day (1). The suprachiasmatic
nucleus (SCN) of the hypothalamus, which is the master
clock in mammals, is entrained by light to keep pace with
the day–night cycle autonomic nerve and humoral factors
coordinate circadian clocks in peripheral tissues (2,3).
Recent studies have also shown that peripheral tissues
contain their own self-sustainable circadian clock oscilla-
tors (4). Moreover, even cultured ﬁbroblasts contain an
active circadian clock, which strikingly resembles the
central clock in the SCN (5–8).
Rhythmic transcription of central and peripheral clock
output genes is controlled by a molecular oscillator, con-
sisting of interlocked positive and negative transcription/
translation feedback loops of a set of clock genes. BMAL1
(MOP3) and CLOCK are basic-helix-loop-helix (bHLH)
PAS transcription factors that dimerize and transactivate
Period (Per1 and Per2), Cryptochrome (Cry1 and Cry2),
and an orphan nuclear receptor, Rev-Erb , via CACGTG
E-box enhancer elements. The PER and CRY proteins act
as negative elements by inhibiting the CLOCK/BMAL1
heterodimer, whereas REV-ERBa regulates Bmal1 gene
expression via ROR responsive elements (RRE) (2,3,9).
Recent reports examining genome-wide gene expression
proﬁles in the SCN and various peripheral organs have
shown that hundreds of genes are expressed under circa-
dian regulation systems (10–12). Curiously, most of the
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suggests that a much larger number of genes are potential
targets of circadian control (13). Thus, each peripheral
tissue or organ cyclically expresses a speciﬁc set of genes
governing tissue-speciﬁc functions, such as cholesterol
metabolism-related genes in the liver (10). Although it is
unquestionably important to study the transcriptional
regulatory network connecting the circadian clock and
physiology, the ﬁndings of micro-array studies are often
too indirect to uncover the distinct regulatory mechanisms
and pathways regulating circadian gene expression.
To further elucidate the circadian transcriptional regu-
latory network, we here establish an eﬀective enhancer-
detecting method to identify enhancers eliciting circadian
gene expression in mammalian cells using an in vitro
random transposon system and a high-throughput
luciferase-based circadian real-time monitoring system.
The expression of Dbp in the SCN, liver and cultured
ﬁbroblast cell lines oscillates very robustly(14,15). In this
study, we ﬁrst showed that a promoter region of the mDbp
gene, which contains  1.4kb upstream from the trans-
criptional start site, generates robust circadian oscillation
of luciferase bioluminescence in rat-1 and NIH3T3 ﬁbro-
blast cells even though no functional circadian enhancer
has been reported. Next, we used an enhancer-trap
approach based on an in vitro transposon system to eﬃci-
ently discover unknown circadian enhancers. Using this
system, we have identiﬁed a circadian enhancer contribut-
ing for cyclic transcriptional regulation in the 50 ﬂanking
region of the mDbp gene. This identiﬁed enhancer is
classiﬁed as a non-canonical E-box (CANNTG), which
is identical with recently reported as a new circadian
enhancer of mDbp promoter (16). Moreover, our observa-
tions suggest that CLOCK/BMAL1-mediated transcrip-
tional regulation may inﬂuence a much larger set of genes
than previously thought; these eﬀects are exerted via not
only CACGTG E-boxes, but also non-canonical
CANNTG E-boxes.
MATERIALS AND METHODS
Cellculture
Rat-1 ﬁbroblast cells (HSRRB, Osaka, Japan), NIH3T3
ﬁbroblast cells, and COS7 cells (kindly donated by Dr
Ishitani, Nagoya University) were cultured in DMEM
with 10% FBS and penicillin–streptomycin. For real-time
analysis, the medium was changed to phenol-red-free
DMEM buﬀered with HEPES at 24h after transfection.
Constructionof transposons forthe enhancer trap
To construct transposons for the enhancer trap, we
used the EZ::Tn
TM pMOD
TM-2<MCS> Transposon
Construction Vector (EPICENTRE Biotechnologies)
(17). We used the PCR-based overlap extension method
to generate fragments carrying the minimal CMV pro-
moter and luciferase reporter gene. First, upper fragments
carrying the minimal CMV promoter were ampliﬁed using
pCMVupKpnI (50-CCGGGGTACCTAGGCGTGTACG
GTGGGAG GCCTATATAAGC-30; the KpnI site is
underlined) and pCMVlowOver (50-CCATGGTGGCAG
GCTGGATCGGTCCCGGTGTCTTCTATGG-30; the
overlapping section is underlined) as primers and the
pTRE2 Vector (CLONTECH) as a template. Lower frag-
ments carrying the luciferase reporter gene were ampliﬁed
using pLUCupOver (50-GGACCGATCCAGCCTGCCA
CCATGGAAGATGCCAAAAAC-30; the overlapping
section is underlined) and pLUClowBamHI (50-TTA
TGGATCCTACCACATTTGTAGAGG TTTTACTT
GC-30; the BamHI site is underlined) as primers and
the pGL4.11 Luciferase Reporter Vector (Promega) as
a template. The upper and lower DNA fragments were
used as templates for a second PCR reaction using
pCMVupKpnI and pLUClowBamHI as primers. The
resulting 2.2kb PCR product was digested with KpnI and
BamHI and ligated to KpnI- and BamHI-digested
pMODTM-2<MCS> Transposon Construction Vector.
The kanamycin resistance gene was ampliﬁed by PCR
using pKmupHindIII (50-TTCGGAAGCTTC AACAAA
GCCACGTTGTGTCTC-30; the HindIII site is under-
lined) and pKmlowHindIII (50-AGCGTAAGCTTCTGC
CAGTGTTACAACCAATTAACC-30; the HindIII site
is underlined) as primers and the EZ::Tn
TM <KAN-2>
Transposon (EPICENTRE Biotechnologies) as a tem-
plate. The resulting 1.0kb PCR product was digested
with HindIII and ligated to the HindIII-digested vector
described earlier to yield the transposon vector for
the enhancer trap. This vector was sequenced to conﬁrm
that no unexpected mutations were introduced. The
larger PshAI fragment from the transposon vector for
the enhancer trap was isolated, puriﬁed by agarose gel
electrophoresis, and used as the transposon for the
enhancer trap.
Enhancer trap
The transposon for the enhancer trap was integrated into
a vector carrying the DBP promoter using EZ::Tn
TM
pMOD
TM Transposase (EPICENTRE Biotechnologies)
according to the manufacture’s instructions. One micro-
liter of transposed sample was transformed into
Escherichia coli. DH5 alpha (Toyobo, Osaka, Japan),
and plasmid DNA was prepared from 48 independent
colonies. One microgram of each plasmid was transfected
into rat-1 cells and bioluminescence was monitored.
Plasmids were sequenced to determine the insertion sites
of the transposon.
Plasmids
The Dbp promoter was obtained by PCR from C57BL/6
mouse genomic DNA using pDbpupSacI (50-AACTC
GAGCTCCACGTCCTGATAGTCTGCAC-30; the SacI
site is underlined) and pDbplowBglII (50-GCTAGAT
CTGTACCAAGTGGGCGAGTCTC-30; the BglII site is
underlined) as primers. The resulting 1.4kb PCR product
was subcloned into the pGEMT-EAZY vector (Promega)
to yield the Dbp promoter vector. In the same way, the
mPer2 and mBmal1 promoters were obtained using the
primer sets pmPer2upKpnI (50-AAGGTACCTCTG
CCGGCTGTGAGTTGCGCAG-30; the KpnI site is
underlined) and pmPer2lowXhoI (50-TTCTCGAGAC
CGCTAGTCCCAGTAGCGCCG-30; the XhoI site
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GCAGAGTCC GCAACGCAGTGG-30; the SacI site is
underlined) and pmBmal1lowXhoI (50-GATCCTCGAG
CGCACCCGCACTCGGATCCCG-30; the XhoI site is
underlined). Each promoter was then ligated into the
pGL4.11 [luc2P] Vector (Promega). To generate a mutated
Dbp promoter reporter vector, a QuikChange site-directed
mutagenesis kit (Stratagene) was used along with the
primers pDbpEbox-mut-up (50-GCACGCGCAAAGC
GGTACCC TTCCCCCTTC-30; substituted nucleotides
are underlined) and pDbpEbox-mut-low (50-GAAGG
GGGAAGGTACCGCTTTGCGCGTGC-30; substituted
nucleotides are underlined). The mutated Dbp promoter
reporter vector was sequenced to conﬁrm the presence of
the speciﬁc mutations and the absence of any unexpected
mutation. The Dbp reporter vector was digested with
KpnI and religated to generate the Dbp(-462):Luc vector.
The mutated Dbp reporter vector was digested with KpnI
and religated to generate the Dbp(-410):Luc vector.
DNA fragments carrying the non-canonical E-box from
the Dbp promoter ( 416) were obtained by PCR using
pDbpNEKpnIup (50-AAGAGGTACCCCTCTTGCCCC
AC-30; the KpnI site is underlined) and pDbpNEKpnIlow
(50-ATATGGTACCAATGGGAGGAGGCGCTG-30;
the KpnI site is underlined) as primers and C57BL/6
mouse genomic DNA as template. The resulting 0.1kb
PCR product was digested with KpnI and subcloned into
KpnI digested transposon vector for the enhancer trap,
described earlier. The reporter vector carrying the non-
canonical E-box from the Dbp promoter was sequenced to
conﬁrm the presence of the expected DNA fragment and
the absence of any unexpected mutations.
Real-time monitoring of bioluminescence
The 2 10
5 rat-1 cells were plated in 35mm dishes or
5 10
4 cells were plated in 24-well plates. For the 35mm
dishes, rat-1 cells were transfected with 1mg of each
construct using 3ml of FUGENE 6 transfection reagent
(Roche). For 24-well plate assays, cells were transfected
with 300ng of each construct and 0.8ml of FUGENE 6.
After overnight culture, medium was changed to DMEM
without phenol-red and containing 100nM luciferin
and 15mM HEPES. After additional overnight culture,
cells were reset with 100nM dexamethasone and
bioluminescence was automatically monitored using a
photomultiplier-tube-based bioluminescence monitoring
system (18).
Transcriptional assays
Luciferase reporter gene assays were performed in
NIH3T3 cells. Cells (2 10
5) were seeded on 6-well
plates and transfected the following day. In this study,
we used the Dual Luciferase reporter assay system
(Promega). Cells in each well were transfected with 50ng
of pGL4.11 vector containing the indicated DNA frag-
ments as described as well as the indicated amounts of
expression plasmids for ﬂag-tagged mClock, mBmal1 and
HA-mCry1pcDNA3.1. The total amount of DNA per well
was adjusted to 1mg by adding pcDNA3 vector as carrier.
Forty-eight hours after transfection, cells were harvested
and luciferase activity was determined by luminometer.
Electrophoretic mobility shift assay(EMSA)
Nuclear extracts were prepared as described (19). Brieﬂy,
COS7 cells expressing ﬂag-tagged mCLOCK and
mBMAL1 were washed with 5ml of Tris-buﬀered saline
(TBS) and pelleted by centrifugation at 1500 g for 5min.
The pellet was resuspended in 1ml of TBS, transferred
into a microtube and centrifuged for 5s. The supernatant
was removed and the pellet was dissolved in 400mlo f
chilled Buﬀer A (10mM HEPES pH 7.9, 10mM KCl,
0.1mM EDTA, 0.1mM EGTA, 1mM DTT and 0.5mM
phenylmethylsulfonyl ﬂuoride). The cells were allowed to
swell on ice for 15min, after which 25ml of 10% NP-40
was added. The tubes were vigorously vortexed for 10s
and centrifuged for 30s at 15000rpm. The nuclear pellet
was dissolved in 50ml ice-cold Buﬀer C (20mM HEPES
ph 7.9, 0.4M NaCl, 1mM EDTA, 1mM EGTA, 1mM
DTT and 1mM PMSF). The nuclear extract was centri-
fuged at 12 000rpm for 5min, and 2ml of the supernatant
was used for each reaction.
The interaction of the BMAL1 and CLOCK proteins
expressed in COS7 nuclei with the DNA fragment
containing the non-canonical E-box enhancer element
of the mDBP promoter was analyzed by EMSAs using
the LightShift Chemiluminescent EMSA Kit (Pierce,
Rockford, IL). The 30bp DNA duplex used in the
EMSA experiments consisted of the annealed pair
of oligonucleotides E-box F (50-GCACGCGCAAAGCC
ATGTGCTTCCCCCTTC-30; the non-canonical E-box is
underlined), and E-box R (50-GAAGGGGGAAGCAC
ATGGCTTTGCGCGTGC-30; the non-canonical E-box
is underlined). These two oligonucleotides were biotiny-
lated at their 50-ends to allow chemiluminescent detection.
DNA–protein binding reactions were carried out at room
temperature and consisted of nuclear extracts mixed with
a reaction buﬀer composed of 10mM Tris–HCl (pH 7.5),
50mM KCl, 1mM DTT, 50ng/ml poly (dI–dC), 2.5%
glycerol, 10mM EDTA (pH 8.0) and 0.05% NP-40.
20fmol of biotin-labeled E-box DNA was then added to
the reaction mixture and incubated for 25min at room
temperature. For competition experiments, a 50-fold
molar excess of unlabeled duplex DNA fragments corre-
sponding to the E-box site (described earlier) was added to
the reaction mixture before addition of the labeled
oligonucleotides. For mutant E-box probe, the annealed
pair of oligonucleotides E-box mut F (50-GCACG
CGCAAAGCGGTACCCTTCCCCCTTC-30; substituted
nucleotides are underlined), and E-box mut R (50-GAA
GGGGGAAGGTACCGCTTTGCGCGTGC-30; substi-
tuted nucleotides are underlined) were used. Reaction
mixtures were analyzed by non-denaturing 6% polyacry-
lamide gel electrophoresis and transferred to Biodyne B
Nylon Membranes (PALL). The biotin-labeled DNA
probes were detected by chemiluminescence using the
Chemiluminescent Nucleic Acid Detection Module Kit
(Pierce). The membranes were exposed to X-ray ﬁlm for
1–3min and developed according to the manufacturer’s
instruction.
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NIH3T3 cells (American Type Culture Collection) were
grown in DMEM (Invitrogen) supplemented with 10%
FBS (JRH Biosciences) and antibiotics (25U/ml penicillin,
25mg/ml streptomycin; Invitrogen). Cells were plated at
6 10
5 cells in 10cm dishes 24h before transfection, and
transfected with two plasmids (6mg each of FLAG tagged
BMAL1 and FLAG tagged CLOCK expression vector)
with FuGene6 transfection reagent (Roche) according to
the manufacturer’s instructions. Cells were harvested 48h
after transfection.
ChIP assays with these transfected NIH3T3 cells were
performed as previously described (20) with the following
modiﬁcations. In this report, we used Chromatin Immu-
noprecipitation Assay Kits (Upstate Biotechnology), anti-
Flag M2 antibody (Sigma) and anti-V5 antibody (Sigma).
Protein G-Sepharose (Amersham) was used for precipita-
tion of antibody/protein immune complexes. The resulting
precipitated DNA was quantiﬁed by Q-PCR, which was
performed according to the previously described method
(21). Absolute DNA abundance was calculated using the
standard curve obtained from NIH3T3 cell’s genomic
DNA. Tbp-50 region were quantiﬁed and used as the
internal control.
Primersequences forQ-PCR of ChIP products
P(Dbp)-forward, 50-TGAACACTCGGCTCCTTTAAG
AG-30;P ( Dbp)-reverse, 50-GCGTGCTATCGGATG
CG-30; Act-50-forward, 50-CCAAGAGGCTCCCTCC
ACA-30; Act-50-reverse, 50-GTGCAAGGGAGAAAGAT
GCC-30; Tbp-50-forward, 50-GTTTGGCTAGGTTTCT
GCGG-30; Tbp-50-reverse, 50-GAAAGGACCGTTAC
CTGGGC-30.
RESULTS
Robustcircadian oscillation driven by the mDbp promoter
The Dbp mRNA is expressed with a robust circadian
rhythm in the SCN, peripheral tissues and cultured cells
(5,22). Recent reports have suggested that a CACGTG
E-box in the second intron of the Dbp gene is likely to be
responsible for this cyclic mRNA expression (14,15).
Although the reported intronic E-box was functional in
response to CLOCK/BMAL1-mediated transcriptional
activation, it is still unknown whether this intronic
E-box is enough to generate robust circadian oscillation.
We ﬁrst focused on the 50 ﬂanking region of the mDbp
gene because many clock genes, including mPers and
Bmal1, have circadian enhancers near their transcription
start sites (12,23,24). We cloned the mDbp promoter
region ( 1332 +83) and fused it upstream of a lucif-
erase reporter gene in the pGL4.11 vector (Promega). This
vector was then transfected into rat-1 ﬁbroblast cells, and
bioluminescence was monitored. Surprisingly, the mDbp
promoter drove luciferase expression with a robust
circadian rhythm; the amplitude of this rhythm was
larger than that of the oscillation driven by the mPer2
or mBmal1 promoters (Figure 1). These results indicate
that the mDbp promoter region contains strong circadian
enhancer(s) that are capable of generating robust oscilla-
tion of expression.
Transposon-based enhancer detection for
the mDbppromoter
To determine the unknown circadian enhancer(s) in the
 1.4kb mDbp promoter region, we developed an
enhancer-detection system based on the Tn5 transposon
for in vitro tranposition. We constructed a transposon
carrying  120bp of minimal CMV promoter fused to a
bioluminescence reporter gene and a kanamycin resistance
gene (Figure 2A). We analyzed the CMV minimal
promoter driven bioluminescence of this trap vector
following transfection into rat-1 cells. As expected, the
bioluminescence was detectable, constitutive, and showed
no circadian intensity changes during several days
(Figure 2B).
The enhancer-detecting transposon vector was ran-
domly integrated into the plasmid carrying the mDbp
promoter in vitro, and each plasmid was sequenced to
determine the transposon insertion site. Eleven diﬀerent
clones with the transposon integrated into the Dbp
promoter region were obtained (Figure 2C). The arrows
in Figure 2C indicate the direction of reporter gene
expression. These plasmids were then transfected into
rat-1 ﬁbroblast cells and bioluminescence was monitored
(Figure S1). Representative results, indicated as (a)–(e), are
shown in Figure 2D. Interestingly, among these ﬁve
bioluminescence proﬁles, (a), (c) and (e) show apparent
circadian oscillation, whereas (b) and (d) show only faint
bioluminescence ﬂuctuation or no apparent circadian
change (Figure 2D). These results suggest that the circa-
dian enhancer(s) in the mDbp promoter may not be active
at long distances from the trap vector. More importantly,
these results indicate that the putativecircadian enhancer is
likely to be located between  700bp (c) and  262bp (a) of
the 50 ﬂanking region of this gene. In additon, there was no
Figure 1. Robust circadian oscillation of mDbp:Luc-driven biolumines-
cence in rat-1 cells. Luciferase reporter constructs driven by the mPer2
promoter (mPer2:Luc, blue), the mBmal1 promoter (mBmal1:Luc,
yellow) and the mDbp promoter (mDbp:Luc, red) were transfected
into rat-1 ﬁbroblasts and synchronized by treatment with 100 nM
dexamethasone. Real-time bioluminescence monitoring showed that all
three promoters were able to drive robust circadian oscillation of the
reporter gene. The phases of the mDbp:Luc and mPer2:Luc-driven
rhythms are quite similar, whereas the mBmal1:Luc driven rhythm is in
almost the opposite phase.
e23 Nucleic Acids Research, 2008, Vol. 36, No. 4 PAGE4 OF10strong circadian enhancer in downstream from the posi-
tion of  335bp, because only faint oscillation was seen in
 335bp integrated one (Figure 2Db). Strikingly, one
transposed clone (f) in Figure 2C, lacking this region did
not show circadian ﬂuctuation of bioluminescence in rat-1
cells (Figure 2D). In addition, a similar transposition,
clone (g), lacking  462 to +83bp, also exhibited almost
no apparent circadian oscillation in bioluminescence com-
pared to (a) or (c) (Figure 2D). This strongly suggests that
the region between  462 and  335bp contains the puta-
tive circadian enhancer responsible for the robust circadian
oscillation of Dbp promoter driven bioluminescence.
Figure 2. Transposon-based in vitro enhancer trap for the mDbp promoter. (A) Structure of the Tn5-based enhancer trap vector. Reduced half-life
ﬁreﬂy luciferase (Luc2P) obtained from the pGL4.11 vector (Promega) is used as a reporter driven by the CMV minimal promoter. ME indicates the
mosaic end sequence to transpose into the host DNA. (B) Real-time bioluminescence monitoring of rat-1 cells transfected with the enhancer trap
vector. Cells are synchronized by treatment with 100nM dexamethasone. No rhythmic ﬂuctuation was observed over a period of 4 days. (C) The
enhancer trap vector was transposed into the  1.4kb fragment of the mDbp promoter cloned into the pGEM T-Easy vector (Promega). After
Ampicillin and Kanamycin selection, 13 clones with integration of the trap vector into the mDbp promoter were obtained. Red arrows indicate the
direction of the luciferase gene in the trap vector. The position of integration is noted for each red arrow. Clones f and g showed integration with
some deletion. (D) Clones with trap vector integrations were transfected into rat-1 cells and analyzed by real-time bioluminescence monitoring.
Representative results from clones a to g are shown. Rat-1 cells transfected with clones a, c or e exhibited robust circadian oscillation
of bioluminescence. In contrast, rat-1 cells transfected with clones b, d, f or g exhibited only faint oscillation.
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promoter containsanon-canonical E-box
Using the in vitro transposon-based enhancer-trap
method, we were able to predict a region that may contain
a strong circadian enhancer. Thus, the next step was to
identify the exact enhancer sequence responsible for mDbp
promoter driven circadian oscillation. Ripperger et al.
reported that CLOCK controls the circadian expression of
the mDbp gene in vivo (14). Moreover, our ﬁndings in this
study show that the phase of mDbp promoter driven
rhythm is similar to the rhythm driven by the mPer2
promoter and opposite from mBmal1 promoter-driven
rhythms (Figure 1). Several studies have indicated that
CLOCK/BMAL1 activate transcription via CACGTG
E-box enhancers existing in various mammalian clock
genes such as mPer1, mCry1, Rev-erb alpha and Dbp.
Recent observations have also shown that CLOCK/
BMAL1 regulate not only CACGTG E-boxes, but also
CACGTT E-box like sequences (25,26). Furthermore, one
recent report suggested that a CANNTG non-canonical
E-box was able to regulate circadian expression of
prolactin (27). Although no CACGTG or CACGTT
E-boxes were seen, several CANNTG sequences exist in
the mDbp promoter region (Figure 3A). Thus, we
investigated the possibility of CLOCK/BMAL1-mediated
regulation of the mDbp promoter region we cloned.
We performed transcriptional assays using the  1.4kb
mDbp promoter-luciferase (Dbp:luc) reporter construct.
Co-transfection ofﬂag-taggedmClockandmBmal1 expres-
sionvectorswiththeDbp:lucreporterresultedinsigniﬁcant
up-regulation of luciferase activity compared to pcDNA3
empty vector co-transfection conditions (Figure 3B).
Moreover, additional expression of mCry1 dramatically
reduced the CLOCK/BMAL1-mediated transcriptional
activity (Figure 3B). These results are consistent with the
reported features of canonical E-boxes, and suggest that
non-canonical E-box(es) in the mDbp promoter are likely
to be functional.
One CANNTG non-canonical E-box sequence was
located in the region predicted to contain the putative
circadian enhancer as shown (Figures 2 and 3A).
To determine whether this non-canonical E-box is the
putative enhancer, we generated deletions of the mDbp
promoter named Dbp( 462):luc and Dbp( 410):luc
(Figure 4A). Strikingly, transcriptional assays showed
that deletion of the region containing the non-canonical
E-box resulted in a loss of responsiveness to co-expression
Figure 4. The predicted circadian enhancer region is essential
for robust circadian oscillation driven by the mDbp promoter.
(A) Deletions of the mDbp promoter: Dbp( 462):Luc contains the
whole predicted enhancer region, Dbp( 410):Luc contains only a
part of the predicted enhancer region. (B) Transcriptional assay using
these reporter constructs. Both Dbp:Luc and Dbp( 462):Luc are
strongly up-regulated (16-fold and 19-fold induction, respectively) by
co-expression of the CLOCK/BMAL1 proteins, whereas the
Dbp( 410):Luc reporter is induced only about 2-fold induction in
response to CLOCK/BMAL1 co-expression. (C) The Dbp( 410):Luc-
driven bioluminescence rhythm exhibits a dampened oscillation of very
low amplitude; in contrast, both Dbp:Luc and Dbp( 462):Luc drive
robust circadian oscillation of bioluminescence.
Figure 3. Transcriptional activation driven by the mDbp promoter is
upregulated by CLOCK/BMAL1 co-expression. (A) Six CANNTG
non-canonical E-boxes are found within the  1.4kb region of the
mDbp promoter that is able to drive robust circadian oscillation of
transcription. Each number indicates the position of a CANNTG
consensus sequence. The red-hashed box represents the location of a
putative strong circadian enhancer as predicted by the enhancer-trap
assay. (B) Transcriptional assay using the mDbp:Luc reporter vector.
Co-expression of ﬂag-tagged mBmal1 and mClock results in a greater
than 8-fold up-regulation of promoter activity. Additional expression of
HA-mCry1 dramatically suppresses mDbp promoter activity.
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importantly, real-time bioluminescence monitoring
showed that the circadian oscillation of Dbp( 410):luc
was dramatically reduced, whereas Dbp( 462):luc exhib-
ited robust circadian oscillation similar to that of Dbp:luc
(Figure 4C). These results indicate that the predicted
circadian enhancer region containing a non-canonical
E-box (CATGTG) was actually responsible for transcrip-
tional activation by the CLOCK/BMAL1 heterodimer
and for exhibiting robust circadian oscillation of biolu-
minescence reporter expression. The weak biolumines-
cence oscillation observed in Dbp( 410):luc transfected
cells may be elicited through another non-canonical E-box
existing in the position of  155bp. In addition, an RRE
compatible sequence (indicated in Figure 3) in mDbp
promoter may be not signiﬁcantly functional, because the
phase of Dbp( 410):luc was still similar to the biolumi-
nescence rhythm driven by other two Dbp promoter
luciferase reporter vectors.
Identification ofthe non-canonicalE-box as
an enhancer contributing for robustcircadian
oscillation driven by the mDbppromoter
To determine whether the non-canonical-E-box
(CATGTG:  416bp from the putative transcription
start site of the Dbp promoter) located in the predicted
circadian enhancer region is actually functional, we
generated a mutation of this non-canonical-E-box in the
Dbp:luc reporter [Dbp(mut):luc] using site-directed muta-
genesis. The non-canonical E-box CATGTG was sub-
stituted with the sequence GGTACC, and transcriptional
assays using the mutated promoter construct were
performed to examine its responsiveness to CLOCK/
BMAL1. The [Dbp(mut):luc] promoter was induced
1.6-fold by CLOCK/BMAL1 co-expression, whereas the
wild-type Dbp:luc promoter was induced 13.5-fold
(Figure 5A). Subsequently, real-time bioluminescence
monitoring was performed using the wild-type and
mutated Dbp promoters. Dbp(mut):luc driven biolumi-
nescence showed very weak circadian oscillation, but the
amplitude of this oscillation was dramatically lower than
that of Dbp:luc-driven bioluminescence oscillation
(Figure 5B). These ﬁndings are consistent with the results
obtained from deletion of this predicted enhancer region
(Figure 4C). Therefore, these results strongly suggest that
the non-canonical E-box located in the predicted circadian
enhancer region was responsible for driving robust cir-
cadian transcriptional oscillation from the Dbp promoter.
Although mutation of CATGTG E-box sequence resulted
in the dramatic damp of promoter driven circadian oscil-
lation, slight circadian rhythm of bioluminescence still
remained. This suggested that other weak circadian
enhancer(s) in part may contribute the transcriptional
rhythm of Dbp gene.
Finally, we investigated the ability of the predicted
enhancer region alone to generate exact circadian oscilla-
tion of gene expression. We subcloned a 127bp DNA
fragment, containing  466 to  340bp of the mDbp
promoter, upstream of a CMV minimal promoter driven
luciferase reporter construct (En+pCMVmin:luc).
Transcriptional assays were performed to examine
the eﬀects of CLOCK/BMAL1 on this DNA fragment.
The relative luciferase activity of En+pCMVmin:luc was
up-regulated after CLOCK/BMAL1 co-expression, and
this transcriptional activity was suppressed completely by
the additional expression of mCRY1 (Figure 6A right).
In contrast, no response was observed inform a CMV
minimal promoter luciferase reporter without the pre-
dicted enhancer DNA fragment (Figure 6A left). Real-
time bioluminescence monitoring demonstrated that the
predicted enhancer region had the ability to generate
circadian gene expression in living rat-1 ﬁbroblast cells
(Figure 6B). These results indicated that the non-canonical
E-box contained in this enhancer region functioned as a
circadian enhancer. Thus, we next conﬁrmed the direct
binding of the CLOCK/BMAL1 complex to this non-
canonical E-box sequence using electrophoretic gel
mobility shift assays (EMSA). When a biotin-labeled
30-bp oligo DNA probe containing the non-canonical
E-box (CATGTG) sequence was incubated with nuclear
extract from COS7 cells transfected with expression
vectors for mClock and mBmal1, a shifted band was
observed (Figure 6C lanes 2 and 3). The speciﬁc band
Figure 5. Mutation of the non-canonical E-box localized in the
predicted circadian enhancer region results in loss of robust circadian
oscillation. (A) Substitution of the CATGTG non-canonical E-box to
GGTACC results in loss of CLOCK/BMAL1-mediated transactivation
of the Dbp:Luc reporter. Mutated Dbp:Luc is named Dbp(mut):Luc.
Relative luciferase activity is reported as mean+SEM (B) Real-time
bioluminescence analysis using wild-type Dbp:Luc (three blue lines) and
Dbp(mut):Luc (three red lines) shows a dramatic dampening of
circadian oscillation in the case of the mutant. Each line represents
one 35-mm dish transfected with Dbp:Luc or Dbp(mut):Luc. Cells were
synchronized by treatment with 100 nM dexamethasone and biolumi-
nescence monitoring was performed using the same photomultiplier.
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(Figure 6C lane 4); in contrast, it was not abolished by
a 50-fold excess of unlabeled probe containing a muta-
tion of the non-canonical-E-box sequence from CATGTG
to GGTACC (Figure 6C lane 5). These results indicate
that the CLOCK/BMAL1 complex directly binds the
CATGTG non-canonical E-box located in the predicted
enhancer region of the mDbp promoter.
Interaction ofBMAL1/CLOCK with Dbppromoter around
identified non-canonicalE-box region inNIH3T3 cells
To conﬁrm the identiﬁed non-canonical E-box actually
functioned in living cells, we performed chromatin
immunoprecipitation (ChIP) using ﬂag-tagged BMAL1
and CLOCK expressed NIH3T3 cells. Co-precipitated
genomic DNA fragments by anti-ﬂag immunoprecipita-
tion were analyzed by quantitative PCR (Q-PCR) method
to detect the identiﬁed non-canonical E-box region.
Position of primer sequences for Q-PCR and the non-
canonical E-box of Dbp promoter region are presented in
Figure 7A. Q-PCR analysis revealed that the signiﬁcant
recruitment of ﬂag-tagged BMAL1 and CLOCK around
the non-canonical E-box region of Dbp promoter
[P(DBP)] was observed, comparing with the beta-actin
promoter region (Act50) as a negative control (Figure 7B).
Figure 6. The isolated predicted circadian enhancer region containing the
non-canonical E-box elicits distinct circadian oscillation. (A) The isolated
predicted circadian enhancer region of the mDbp promoter was subcloned
into the pCMVmin:Luc reporter vector, and strong up-regulation of
transcriptional activity was observed after co-expression of CLOCK/
BMAL1. CLOCK/BMAL1-mediated transcriptional activity was drama-
tically reduced by the additional expression of HA-mCRY1. In contrast,
the pCMVmin:Luc vector without the non-canonical E-box showed
no response to co-expression of CLOCK/BMAL1 and HA-mCRY1.
(B) Real-time bioluminescence monitoring of pCMVmin:Luc with or
without the non-canonical E-box. The pCMVmin:Luc vector exhibited
no cyclic ﬂuctuation of bioluminescence over 3 days; in contrast, the
En+pCMVmin:Luc vector, which contains the predicted circadian
enhancer elicited apparent circadian oscillation of bioluminescence
(red line). (C) Electrophoretic gel mobility shift assays (EMSA) indicate
direct binding of the CLOCK/BMAL1 complex to the CATGTG non-
canonical E-box located in the predicted circadian enhancer region of the
mDbp promoter. Shifted bands are detected when labeled non-canonical
E-box probe is incubated with nuclear extract from CLOCK/BMAL1
expressing COS7 cells (lanes 2 and 3); incubation with an excess of
unlabeledproberesultsindramaticreductionoftheshiftedbands(lane4).
Anexcessofunlabeledmutatednon-canonicalE-boxprobe(CATGTGto
GGTACC) does not reduce the shifted band (lane 5). Asterisks indicate
non-speciﬁc bands.
Figure 7. BMAL1/CLOCK binds the endogenous non-canonical E-box
region of 50 ﬂank end of the Dbp gene in NIH3T3 cells. Chromatin
immunoprecipitation (ChIP) was performed to analyze the binding of
BMAL1/CLOCK with the endogenous non-canonical E-box identiﬁed in
this study. (A) The position of identiﬁed non-canonical E-box is indicated
as underline (NC E-box). Arrows below the DNA sequences indicate the
primers [P(DBP)-F and P(DBP)-R] to detect co-immunoprecipitated
target Dbp promoter region. (B) ChIP is performed using ﬂag-tagged
BMAL1/CLOCK expressed NIH3T3 cells. Quantitative PCR (Q-PCR)
using P(DBP)-F and P(DBP)-R primers revealed that ampliﬁed signals
from the precipitants with anti-Flag antibody are signiﬁcantly stronger
than the signals ampliﬁed from the precipitants using anti-V5 antibody as
a control (left two columns). As a negative control, Q-PCR using speciﬁc
primers for beta-actin promoter (Act50) shows that ampliﬁed signals from
precipitant samples using anti-ﬂag or anti-V5 antibodies both are low and
no signiﬁcant diﬀerence between them (right two columns). Error bars
indicate standard deviation (SD).
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CLOCK expressed NIH3T3 showed no signiﬁcant diﬀer-
ence between P(DBP) targeted and Act50-targeted Q-PCR
(Figure 7B). These results conﬁrmed that BMAL1/
CLOCK actually bound the 50 ﬂank region of Dbp gene
around the identiﬁed non-canonical E-box.
DISCUSSION
In this study, we have presented that we developed a
transposon-based in vitro enhancer trapping method,
which is a new strategy to identify unknown enhancers
contributing to circadian gene expression in living cells.
Using this method, we determined that the CATGTG
sequence, which can be classiﬁed as a CANNTG
non-canonical E-box, at position  416bp in the mDbp
promoter functioned as a strong circadian enhancer to
elicit robust oscillation of mDbp promoter driven lucifer-
ase bioluminescence. These results were compatible with
recent study showing that this non-canonical E-box
actually functioned as a circadian enhance in vivo (16).
Transposon-based enhancer detection system
In this study, we developed a Tn5 transposon-based
in vitro enhancer detection vector to identify unknown
circadian enhancer elements. The Tn5 transposon system
was originally developed for mutagenesis of bacterial
genes in vitro and in vivo (17). However, this system is also
useful for examining mammalian genes in vitro when the
target DNA fragments are subcloned into a cloning
vector. Therefore, we used this transposon system to try
to trap putative enhancer elements. Moreover, using short
half-life ﬁreﬂy luciferase (from pGL4.11, Promega), we
were able to analyze real-time transcriptional activity for
several days following transfection of this trap vector into
rat-1 cells. Combining the newly generated enhancer trap
vector with high throughput real-time bioluminescence
monitoring allowed us to detect a highly dynamically
controlled circadian enhancer element. As shown in
Figure 2, some of the transposons integrated into the
mDbp promoter exhibited apparent circadian biolumi-
nescence cycles, whereas others did not (Figure 2). This
indicated that the circadian enhancer in the mDbp pro-
moter must localized on the up-stream of the luciferase,
and allowed us to identify the CATGTG non-canonical
E-box as a strong circadian enhancer driving robust
circadian oscillation.
Another interesting point of this study is why these
circadian enhancers exhibit ‘positional eﬀect’ or ‘distance
eﬀect’. In general, it is known that an enhancer shows its
function without any relation of distance and direction.
However, our strategy was actually useful to ﬁnd out the
non-canonical E-box enhancer. Although we have not yet
had exact answer for this question, one speculation is that
the position of BMAL1/CLOCK E-box may be important
for expressing its function. Because in many clock genes
having E-box on their promoter, the E-boxes reside near
transcriptional start sight in many case. The exact answer
should be waited for further studies.
This study used transient transfections to analyze the
real-time bioluminescence driven by the enhancer detec-
tion vector. We were able to predict the circadian
enhancer region of the mDbp promoter based on the
amplitudes of reporter oscillation observed in trap vector
integrated clones; this suggests that our in vitro enhancer
trap strategy is a powerful and convenient method to
identify unknown enhancers. Furthermore, much micro-
array data has recently become available in public
databases. Using these data, in vitro enhancer trapping
may become a much more eﬀective way to understand the
regulatory mechanisms of gene expression.
Anon-canonical E-boxas astrong circadian enhancer
Here, we have identiﬁed a CATGTG non-canonical E-box
as a strong circadian enhancer driving an mDbp promoter
luciferase reporter with clear circadian rhythm. One report
recently suggested that a CANNTG non-canonical E-box
(CATTTG) in the prolactin promoter is regulated by the
CLOCK/BMAL1 complex (27). These results showed
that both CACGTG canonical E-boxes and CANNTG
non-canonical E-boxes could be important circadian
enhancers. On the other hand, our ﬁndings raise a new
question. The CANNTG sequence is mathematically
predicted to appear once every 256bp in the genome.
This means that circadian enhancers may exist widely in
the promoters and intronic regions of many genes. Storch
et al. reported that hundreds of genes are cyclically
expressed in liver and heart; however, most of these genes
do not overlap in both organs (11). Other microarray
studies have supported the idea of divergent circadian
gene expression in a tissue-speciﬁc manner (10,12). These
studies suggest the possibility that a large number of genes
have the potential to exhibit circadian expression under
appropriate conditions (13). In addition, our data showed
that weakly but apparent circadian oscillation of biolu-
minescence was still remained even this non-canonical
E-box enhancer was mutated (Figure 5B). These results
may suggest that other weakly functioned unknown
circadian enhancers still existed on the mDbp promoter
region or other mechanism (for example, chromatin
remodeling) would contribute for circadian gene expres-
sion. Another important and interesting question arising
from this study is how the circadian system selectively
regulates gene expression. Tissue-speciﬁc circadian gene
expression may be controlled by a combination of
enhancer and tissue-speciﬁc regulatory factors, such as
the genome sequence around the non-canonical E-boxes
or chromatin regulatory mechanisms. Further studies are
required to address these questions.
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